Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab), SIMPONI ARIA (golimumab), STELARA (ustekinumab), TREMFYA (guselkumab), EDURANT (rilpivirine), and INVEGA SUSTENNA/XEPLION (paliperidone palmitate). The MedTech segment includes a portfolio of products used in cardiovascular, orthopedics, surgery, and vision categories. The Cardiovascular portfolio includes electrophysiology products to treat heart rhythm disorders and circulatory restoration products (Shockwave) for the treatment of calcified coronary artery disease (CAD) and peripheral artery disease (PAD).
Johnson & Johnson (XNYS-JNJ)
In STOCKS
Tap into 10 years of rich financial and market data, designed to support deep analysis and smarter decision making. Whether you’re tracking fiscal trends or monitoring market shifts, our platform gives you the insights in detail.
Need more than what’s standard? Submit a custom request and we’ll build a dataset that fits your exact needs. Whether it’s 10+ years of history, alternative data, or integration-ready formats just ask.
Available
Financial Data
Dive into detailed company financials — income statements, balance sheets, cash flow, and key ratios.
Explore comprehensive fiscal trends
Market Data
Access high-frequency market data — tick-level movements, hourly candles, and intraday trends or market snapshots.
Up to the tick market movements
Extended Data
Request tailored datasets — historical depth, alternative data sources, live data or custom formats.
Customized data sets to go beyond the basics
Got questions?
Feel free to reach out.